Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune Responses to Two BCG Vaccinations in Healthy Adults
NCT03175380Phase 1Completed
- Sponsor
- Aeras Global Vaccine Foundation
- Start
- Aug 2017
- Primary completion
- Jan 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of bcg vaccine in Tuberculosis (TB), sponsored by Aeras Global Vaccine Foundation. Primary endpoint: Biological samples at 8 months. Started Aug 2017; status: completed.
02
Drugs
bcg vaccine
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT03175380.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03175380.